Physician profile
Kathy Dang
NPI 1255000584
$3,903.16
in general payments reported to CMS, 2019-2025
20 companies · $1,198 in 2025
The $1,198 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $672 · 2023: $719 · 2024: $1,059 · 2025: $1,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,975.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,430.83 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $430.45 | 2022-2024 | Andexxa |
| Motiva USA, LLC | $263.70 | 2025 | |
| Novo Nordisk INC | $174.12 | 2021-2023 | |
| Tela Bio, INC. | $171.97 | 2024 | Ovitex 2s |
| Amgen INC. | $141.81 | 2025 | Tepezza |
| Axogen | $138.84 | 2025 | |
| Sobi, INC | $120.75 | 2023 | |
| Jazz Pharmaceuticals INC. | $119.74 | 2021 | |
| Alexion Pharmaceuticals, INC. | $118.48 | 2021 | |
| Stemline Therapeutics INC. | $115.61 | 2022 | |
| Genzyme Corporation | $101.60 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $99.97 | 2023 | |
| Medical Device Business Services, INC. | $99.74 | 2023 | Linx Reflux Management System |
| Convatec INC. | $85.43 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $79.13 | 2024 | Veklury |
| Stryker Corporation | $72.67 | 2023 | Mako |
| Aroa Biosurgery Incorporated | $48.91 | 2024 | |
| Coloplast Corp | $45.66 | 2023 | Altis, Titan |
| Acera Surgical, INC. | $43.75 | 2024 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathy Dang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.